The Federal Trade Commission’s approval of Abbott Laboratories’ $25 billion purchase of St. Jude Medical helps the larger company cope with value-based care and bundled payments to doctors and hospitals.

from Forbes – Tech http://ift.tt/2hw7ieQ
via IFTTT